Health Affairs Briefing on Non-Communicable Diseases, Sept. 9
Health Affairs Briefing, September 9, 2015
Non-Communicable Diseases: The Growing Burden
While growing wealth has reduced the burden of infectious diseases both globally and here at home, it has increased the risk factors for some chronic diseases. Heart disease, respiratory disease, cancer, diabetes, mental illness, and other noncommunicable diseases demand our attention. The September 2015 issue of Health Affairs, “Noncommunicable Diseases: The Growing Burden,” takes a broad look at the global impact of NCDs and responses to them.
You are invited to join us on Wednesday, September 9, 2015, at a forum featuring authors from the new issue at the Capital Hilton Hotel in Washington, DC. Panels will cover Incidence of Non-Communicable Diseases, Economics and Finance, Prescription Drugs and NCDs, and Community Interventions and NCDs. Among the confirmed speakers are:
- Mohammed K. Ali, Associate Professor, Hubert Department of Global Health, Rollins School of Public Health, Emory University, on Noncommunicable Diseases: Three Decades Of Global Data Show A Mixture Of Mortality Rate Increases And Decreases
- Thomas J. Bollyky, Senior Fellow for Global Health, Economics, and Development, Council on Foreign Relations, on Understanding The Relationships Between Noncommunicable Diseases, Unhealthy Lifestyles, And Country Wealth
- Edwin B. Fisher, Professor, Health Behavior and Health Education, University of North Carolina at Chapel Hill, on Key Features Of Peer Support In Chronic Disease Prevention And Management
- Thomas Gaziano, Assistant Professor, Cardiovascular Division, Brigham and Women’s Hospital, on Increasing Prescription Length Could Cut Cardiovascular Disease Burden And Produce Savings In South Africa and Cardiovascular Disease Screening By Community Health Workers Can Be Cost-Saving And Cost-Effective In Low-Resource Countries
- Sandeep P. Kishore, Fellow Yale University and President, Young Professionals Chronic Disease Network, on Overcoming Obstacles To Access Noncommunicable Disease Medicines In Poor Countries
- Felicia Knaul, Associate Professor, Harvard Medical School, and Director, Harvard Global Equity Initiative, on Effective Universal Health Coverage And The Challenge Of Chronicity: A Diagonal Response To Breast Cancer
- Ankita Meghani, Research Fellow, Department of Medicine, Stanford University School of Medicine, on A Review Of Innovative International Financing Mechanisms To Address Noncommunicable Diseases
- Bart Peterson, Senior Vice President, Corporate Affairs and Communications, Eli Lilly and Company
- M. Christopher Roebuck, President and CEO, RxEconomics, on Increased Use Of Prescription Drugs Reduces Medical Costs In Medicaid Populations
- Joshua A. Salomon, Professor of Global Health, Harvard T.H. Chan School of Public Health, on Estimating The Impact Of Insurance Expansion On Undiagnosed And Uncontrolled Chronic Conditions
- Jonathan Samet, Distinguished Professor and Flora L. Thornton Chair, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, on Framing Progress In Global Tobacco Control To Inform Action On Noncommunicable Diseases
- Trishul Siddharthan, Fogarty Global Health Fellow in Kampala, Uganda, and Fellow, Department of Pulmonary and Critical Care, Johns Hopkins University, on Noncommunicable Diseases In East Africa: Assessing The Gaps In Care And Identifying Opportunities For Improvement
Health Affairs is grateful to Eli Lilly and Company for its generous support of the issue and event.
Wednesday, September 9, 2015
9:00 a.m. – Noon
Capital Hilton Hotel
1001 16th Street NW
You may follow live Tweets from the briefing @Health_Affairs, and join in the conversation with #HA_NCDiseases.